.
Factors that may influence the conversion of PrP
include the unfolded state that is associated with transport from ER to the cytosol, interactions with cytosolic chaperones, the reducing environment of the cytosol, the unglycosylated state of the transported protein, the local concentration of cytosolic PrP, the efficiency of the proteasome, and the effect of specific mutations on folding. The gastric pathogen Helicobacter pylori is known to be able to use molecular hydrogen as a respiratory substrate when grown in the laboratory. We found that hydrogen is available in the gastric mucosa of mice and that its use greatly increased the stomach colonization by H. pylori. Hydrogenase activity in H. pylori is constitutive but increased fivefold upon incubation with hydrogen. Hydrogen concentrations measured in the stomachs of live mice were found to be 10 to 50 times as high as the H. pylori affinity for hydrogen. A hydrogenase mutant strain is much less efficient in its colonization of mice. Therefore, hydrogen present in animals as a consequence of normal colonic flora is an energy-yielding substrate that can facilitate the maintenance of a pathogenic bacterium.
The bacterial oxidation of molecular H 2 commonly occurs in nature, as hydrogen gas released by other bacteria represents a useable high-energy reductant (1) . Once H 2 is bound and "split" by a membrane-associated hydrogenase, further oxidation-reduction and energy-generating steps are facilitated by a series of membrane-bound heme-containing electron carriers. Hydrogen is a by-product of colonic fermentation (2) , and hydrogen has been reported to be produced (measured as excreted gas) in the gastrointestinal tract of both rodents (3) and humans (4). However, whether molecular hydrogen is used as an energy reservoir for pathogenic bacteria residing in animals is not known. To help understand the microbial communities associated with digestion, H 2 levels were determined in the termite hind-gut (5) and recently from the cockroach midgut (6), but H 2 levels in tissues of vertebrate animal hosts has not been assessed. Helicobacter pylori is a pathogen that solely colonizes the mucosal surfaces of the human stomach, where it gives rise to gastritis and peptic ulcers and is correlated with the development of certain types of gastric cancer (7) . We previously reported that lab-grown H. pylori can express a membranebound "uptake-type" hydrogenase (8 and its use as an energy source is a formerly unrecognized factor in understanding how a human pathogen grows and persists in an animal host. One hallmark of the energy-conserving uptake hydrogenases is the ability to respond positively to exogenously supplied hydrogen (9, 10) . Hydrogenase activity (11) in H. pylori is constitutive under all conditions we have tested, but in a chemically defined media (12) amperometrically determined hydrogenase activity (13) A much milder stimulation of hydrogenase activity occurs when the cultures are grown in rich media or on blood-containing plates (BA plates) (13) , in which hydrogenase activity is stimulated approximately twofold by the addition of 10% hydrogen (14 ) . To characterize hydrogenase regulation, we used promoter fusions with the reporter gene xylE (15) from Pseudomonas putida to generate catechol 2,3-dioxygenase, which can be easily assayed spectrophotometrically (13) . We assayed XylE activity in H. pylori strains carrying plasmids with hydrogenase structural gene promoter-xylE fusion ( phyd: xylE), a nonhydrogenase related promoterxylE fusion ( pHP0630:xylE), and a promoterless xylE gene ( pHel:xylE). The results ( Table 1) show that hydrogenase is regulated at the transcriptional level. The gene directly adjacent to hydrogenase (designated HP0630 and annotated as conserved; no known function in the sequenced strain 26695) (16 ) is not regulated by hydrogen, and no XylE activity was seen in the strain harboring a promoterless xylE gene ( Table  1) . Hydrogenase transcription was not affected by other environmental conditions such as pH or oxygen concentration (14 ) , and proper regulation of the hydrogenase operon (as measured by phyd:xylE) is retained in the hydrogenase structural gene mutant Hyd:cm (14 ) , indicating that hydrogenase is not self-regulated. That the enzyme expression responds to molecular hydrogen availability supports our previous proposal (8) that the role of hydrogenase is in respiratory hydrogen oxidation. A whole-cell Michaelis constant (apparent K M ) for hydrogen was determined to be 1.8 M, indicating a very high affinity for hydrogen, and a value similar to the wholecell affinities of other hydrogen-oxidizing bacteria (17 ) . The method used (17 ) to determine this K M uses live, intact cells with O 2 available as the only terminal electron acceptor in the H 2 oxidizing respiratory chain. Therefore, our measured apparent K M is for the entire hydrogen oxidizing system. We have previously shown that hydrogen oxidation in H. pylori grown in an H 2 -containing atmosphere is linked to cytochrome reduction, with the heme-containing components functioning as intermediate electron carriers before reduction of the terminal (O 2 -binding) oxidases (8) .
Hydrogenase mutants in the SS1 (mouse colonization strain) background (SS1:Hyd) are deficient in their ability to colonize in mice. From two separate mouse colonization studies, only 24% (9 of 38) of the hydrogenase mutant-inoculated mice were colonized, as compared to 100% (37 of 37) colonization when inoculated with the parent strain (Fig. 1) . The colonization efficiency of the mutant strain correlates with the inoculum dosage, with only 15% colonization at a inoculation dose of 2 ϫ 10 8 ( Fig. 1A) but 33% colonization at a inoculation dose of 1 ϫ 10 9 (Fig 1B) . SS1-inoculated mice were 100% colonized (the strain was able to colonize every mouse) at both inoculation doses when we used an initial "two-dose" regimen for inoculation (13) .
We determined the average hydrogen content of the mucus layer of the mouse stomach to be 43 M, over 20 times as much as that of the apparent whole-cell K M for hydrogen. This concentration represents the average of 31 measurements taken from different regions of stomachs from four live, anesthetized mice (13) ( Table 2) . These measurements were taken on different days and at different times during the day and ranged in concentrations from 17 to 93 M, indicating that under most conditions the hydrogen oxidizing system in H. pylori would be saturated. It may be expected that the type of diet of the animal would affect the colonic flora fermentation responses; diet would then affect the hydrogen concentrations in tissues, but was not studied here.
A wide range of characteristics attributed to infectious bacteria are classified as virulence determinants to successfully combat inherent host protection mechanisms. However, the primary sources of energy used by infectious bacteria to sustain their growth, once they are established in an animal host, remain largely unknown (18) . The use of molecular H 2 , a highenergy, diffusible reductant produced by colonic fermentations from other host-residing bacteria, thus represents a useful tool for understanding how a human pathogen grows and persists in an animal host. Hydrogen use may play an especially important role in setting up the stable infection required for the most serious of the pathologies associated with H. pylori infection, gastric ulceration, and cancer. Blood-or serum-containing media is commonly used for routine (laboratory) culture of H. pylori, and the nature of the carbon and energy sources used in the host are unknown. Helicobacter pylori is very limited in its use of oxidizable carbon substrates (19) , and the primary environment for H. pylori colonization is within the complex and viscous mixture of glycoproteins known as mucin. This is expected to provide little nutritional value for the pathogen. Fermentation reactions in the colon include the hydrogenproducing reactions accompanied by acetate and butyrate production by bacteria of the anaerobic large intestine (2). This colonic H 2 must move into other tissues, presumably by a combination of cross-epithelial diffusion (6 ) and vascular-based transport processes (20) . Indeed, it has been estimated that 14% of all the intestinalproduced hydrogen is excreted through the breath (of humans), and the authors speculate that the hydrogen is carried to the lungs via the bloodstream (4 ). The proportion of exhaled gas as H 2 can vary considerably among individuals (2, 4 ), so it may be possible to correlate H. pylori infection with inherent host H 2 -production characteristics. From our studies, H 2 use must represent a large energy boost for a bacterium living in an energy-poor environment (such as gastric mucosa). H 2 is an energy substrate not used by the host, so competition for this high-energy substrate in the gastric environment is not a factor. Also, some other human pathogens contain uptake-type hydrogenases, so H 2 utilization within animal hosts may extend beyond just H. pylori and gastric infections. (21), the parent strain results (both experiments) are significantly greater than the mutant at the 99% degree of confidence (␣Ј equals 0.01, for a one-tailed test). This conclusion was so even if the undetectable CFU's (most of the data points for the mutant) were assumed to be 1 ϫ 10 3 CFU of H. pylori per gram of stomach. N-linked protein glycosylation is the most abundant posttranslation modification of secretory proteins in eukaryotes. A wide range of functions are attributed to glycan structures covalently linked to asparagine residues within the asparagine-X-serine/threonine consensus sequence (Asn-Xaa-Ser/Thr). We found an N-linked glycosylation system in the bacterium Campylobacter jejuni and demonstrate that a functional N-linked glycosylation pathway could be transferred into Escherichia coli. Although the bacterial N-glycan differs structurally from its eukaryotic counterparts, the cloning of a universal N-linked glycosylation cassette in E. coli opens up the possibility of engineering permutations of recombinant glycan structures for research and industrial applications.
Glycosylation has generally been considered to be restricted to eukaryotes where the attachment of glycan structures to proteins usually occurs at an Asn-Xaa-Ser/Thr consensus (Nlinked) or at Ser/Thr residues (O-linked). It is now evident that protein glycosylation is also abundant in prokaryotes (1, 2) . N-linked protein glycosylation of S-layer proteins seems to be restricted to the archaeal domain, whereas serine-, threonine-, or tyrosine-linked (Olinked) glycosylation is predominantly found in bacteria. However, specific N-glycoproteins in bacteria have been reported (3) . N-linked glycosylation is the most frequent protein modification in eukaryotes. In the central step of the process that takes place at the luminal side of the endoplasmic reticulum (ER) membrane, a preassembled oligosaccharide (Glc 3 Man 9 GlcNAc 2 , where Glc is glucose, Man is mannose, and GlcNAc is N-acetylglucosamine) is transferred from the lipid carrier dolichyl pyrophosphate to asparagine residues of nascent polypeptide chains by the oligosaccharyltransferase (4). Such general glycosylation systems have not been described in prokaryotes, with the exception of the enteropathogenic bacterium Campylobacter jejuni, where the pgl gene cluster (Fig. 1A) seems to encode a general protein glycosylation system (5, 6) . A number of pgl genes encode proteins with sequence similarity to glycosyltransferases and to enzymes required for sugar biosynthesis, a fact that supports this hypothesis. The pglB gene encodes a protein with strong similarity to Stt3p found exclusively in eukaryotes and in archaea but not in any other bacterial species (Fig. 1B) . Genetic and biochemical studies in yeast have demonstrated that the Stt3 protein is an essential component of the oligosaccharyltransferase complex (7) (8) (9) , the central enzyme in the process of N-linked protein glycosylation. In eukaryotes, the oligosaccharyltransferase complex consists of at least eight different subunits (8) , yet, the precise catalytic mechanism of this enzyme is unknown (10-12) .
To analyze the pgl glycosylation system, we constructed a C. jejuni pglB mutant strain and probed the membrane protein extract with a polyclonal antiserum raised against C. jejuni whole-cell extracts ( Fig. 2A) (13) . The reactivity of this antiserum is markedly reduced by prior treatment of C. jejuni proteins with a deglycosylating agent, indicating that the glycan portion of C. jejuni glycoproteins is highly immunogenic (5) . Mutation of the pglB gene also resulted in changes to the immunoreactivity of C. jejuni membrane proteins ( Fig. 2A) suggesting that PglB was involved in the biosynthesis of these putative glycoproteins. This mutant phenotype was partially complemented by introducing the 16-kilobase pgl locus on a plasmid. We attributed the partial complementation of the pglB mutant phenotype to the instability of the large plasmid in C. jejuni. Our experiments confirmed a direct involvement of PglB in the generation of glycoproteins in C. jejuni (5) . One of the immunoreactive proteins (arrow in Fig. 2A ) was purified from the C. jejuni extract and identified by matrixassisted laser desorption/ionization (MALDI) mass mapping as the periplasmic AcrA (Cj0367c). An acrA deletion mutant of C. jejuni was analyzed by immunoblot analysis using the glycoprotein-specific antiserum. The 47-kD immunoreactive protein was absent in acrA mutant cells, and this phenotype was complemented by the expression of plasmid-borne acrA gene ( Fig. 2A) . Antiserum raised against recombinant C. jejuni AcrA produced in Escherichia coli revealed mature protein migrating at an apparent molecular size of 47 kD (Fig. 2B) . In contrast to the glycoprotein-specific serum ( Fig. 2A) , an unglycosylated AcrA with increased mobility was recognized by the AcrA-specific antibodies in a pglB mutant strain (Fig. 2B) . Partial complementation of the pglB phenotype was achieved with the pgl locus, as visualized by three distinct AcrA-specific bands. Thus, mature AcrA carries two oligosaccharide modifications, and partial complementation of the pglB mutation resulted in diglycosylated, monoglycosylated, and nonglycosylated AcrA protein. Only the two former forms were recognized by the glycosylation-specific serum. Therefore, AcrA was a target for the general glycosylation system and glycosylation required the pgl gene cluster, in particular PglB activity.
